96 related articles for article (PubMed ID: 16414141)
21. StpC-based gene therapy targeting latent reservoirs of HIV-1.
Turner LS; Tsygankov AY; Henderson EE
Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow-derived cells migrate to line the vessels of the CNS: opportunities for gene delivery to CNS vasculature.
Louboutin JP; Chekmasova AA; Reyes BA; Van Bockstaele EJ; Strayer DS
Neuroscience; 2011 Nov; 195():215-23. PubMed ID: 21906658
[TBL] [Abstract][Full Text] [Related]
23. Trans-activated interferon-alpha2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle.
Cordelier P; Calarota SA; Strayer DS
J Hematother Stem Cell Res; 2002 Oct; 11(5):817-28. PubMed ID: 12427288
[TBL] [Abstract][Full Text] [Related]
24. Development of targeted gene transfer into human primary T lymphocytes and macrophages using high-titer recombinant HIV vectors.
Miyake K; Miyake N; Shimada T
J Biotechnol; 2007 May; 129(3):532-8. PubMed ID: 17307270
[TBL] [Abstract][Full Text] [Related]
25. GFP-lentiviral vectors targeting for neuroAIDS.
Lu Y
Methods Mol Biol; 2009; 515():177-97. PubMed ID: 19378133
[TBL] [Abstract][Full Text] [Related]
26. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
Berger G; Goujon C; Darlix JL; Cimarelli A
Gene Ther; 2009 Jan; 16(1):159-63. PubMed ID: 18668143
[TBL] [Abstract][Full Text] [Related]
27. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer to the cerebellum.
Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Cerebellum; 2010 Dec; 9(4):587-97. PubMed ID: 20700772
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.
Sakuma R; Noser JA; Ohmine S; Ikeda Y
Gene Ther; 2007 Jan; 14(2):185-9. PubMed ID: 16943852
[TBL] [Abstract][Full Text] [Related]
30. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications.
Agrawal L; Louboutin JP; Strayer DS
Virology; 2007 Jul; 363(2):462-72. PubMed ID: 17336361
[TBL] [Abstract][Full Text] [Related]
31. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
[TBL] [Abstract][Full Text] [Related]
32. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1.
Gekker G; Hu S; Sheng WS; Rock RB; Lokensgard JR; Peterson PK
Int Immunopharmacol; 2006 Jun; 6(6):1029-33. PubMed ID: 16644490
[TBL] [Abstract][Full Text] [Related]
33. Cell transplantation to the brain with microglia labeled by neuropathogenic retroviral vector system.
Watanabe R; Takase-Yoden S; Fukumitsu H; Nakajima K
Cell Transplant; 2002; 11(5):471-3. PubMed ID: 12382676
[TBL] [Abstract][Full Text] [Related]
34. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC).
Sun L; Zhang Y; Huang CX; Qu XL; Zhang Y; Zhang JC; Wei X; Zhuang Y; Zhai S; Peng MJ; Jiang H; Hao CQ; Li YH; Lu J; Lian JQ; Sun YT; Bai XF
J Virol Methods; 2008 Dec; 154(1-2):194-9. PubMed ID: 18706447
[TBL] [Abstract][Full Text] [Related]
36. Combination genetic therapy to inhibit HIV-1.
Strayer DS; Branco F; Landré J; BouHamdan M; Shaheen F; Pomerantz RJ
Mol Ther; 2002 Jan; 5(1):33-41. PubMed ID: 11786043
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated gene transfer to the rat, ovine and human cornea.
Parker DG; Kaufmann C; Brereton HM; Anson DS; Francis-Staite L; Jessup CF; Marshall K; Tan C; Koldej R; Coster DJ; Williams KA
Gene Ther; 2007 May; 14(9):760-7. PubMed ID: 17301843
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the host factors necessary for HIV-1 replication--an evaluation through experimental fusion of HIV-1-infected rat cells and human cells].
Hokkaido Igaku Zasshi; 2005 Jul; 80(4):403-11. PubMed ID: 16107055
[No Abstract] [Full Text] [Related]
40. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication.
Asparuhova MB; Barde I; Trono D; Schranz K; Schümperli D
J Gene Med; 2008 Oct; 10(10):1059-70. PubMed ID: 18642399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
